Does Medicaid pay too much for precscription drugs?: a case study of atypical anti-psychotics
Gespeichert in:
1. Verfasser: | |
---|---|
Format: | Buch |
Sprache: | English |
Veröffentlicht: |
Cambridge, Mass.
National Bureau of Economic Research
2003
|
Schriftenreihe: | National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series
9626 |
Schlagworte: | |
Online-Zugang: | Volltext |
Beschreibung: | 34, [15] S. |
Internformat
MARC
LEADER | 00000nam a2200000zcb4500 | ||
---|---|---|---|
001 | BV023590274 | ||
003 | DE-604 | ||
005 | 20090806 | ||
007 | t | ||
008 | 021128s2003 xxu |||| 00||| eng d | ||
035 | |a (OCoLC)249017623 | ||
035 | |a (DE-599)BVBBV023590274 | ||
040 | |a DE-604 |b ger | ||
041 | 0 | |a eng | |
044 | |a xxu |c XD-US | ||
049 | |a DE-521 |a DE-19 | ||
084 | |a 15,3 |2 ssgn | ||
100 | 1 | |a Duggan, Mark G. |d 1970- |e Verfasser |0 (DE-588)129714402 |4 aut | |
245 | 1 | 0 | |a Does Medicaid pay too much for precscription drugs? |b a case study of atypical anti-psychotics |c Mark G. Duggan |
264 | 1 | |a Cambridge, Mass. |b National Bureau of Economic Research |c 2003 | |
300 | |a 34, [15] S. | ||
336 | |b txt |2 rdacontent | ||
337 | |b n |2 rdamedia | ||
338 | |b nc |2 rdacarrier | ||
490 | 1 | |a National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series |v 9626 | |
648 | 4 | |a 1993-2001 | |
650 | 4 | |a Medicaid | |
650 | 4 | |a Verschreibungspflichtiges Arzneimittel | |
650 | 4 | |a Gesetzliche Krankenversicherung / Sozialhilfeempfänger / Pharmazeutisches Produkt / Psychopharmakon / Preis / Gesundheitskosten / Innovation / Produktivität / Gesundheit / Schätzung / Kalifornien / USA | |
776 | 0 | 8 | |i Erscheint auch als |n Online-Ausgabe |
830 | 0 | |a National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series |v 9626 |w (DE-604)BV002801238 |9 9626 | |
856 | 4 | 1 | |u http://papers.nber.org/papers/w9626.pdf |z kostenfrei |3 Volltext |
999 | |a oai:aleph.bib-bvb.de:BVB01-016905604 |
Datensatz im Suchindex
_version_ | 1804138246142164992 |
---|---|
adam_txt | |
any_adam_object | |
any_adam_object_boolean | |
author | Duggan, Mark G. 1970- |
author_GND | (DE-588)129714402 |
author_facet | Duggan, Mark G. 1970- |
author_role | aut |
author_sort | Duggan, Mark G. 1970- |
author_variant | m g d mg mgd |
building | Verbundindex |
bvnumber | BV023590274 |
ctrlnum | (OCoLC)249017623 (DE-599)BVBBV023590274 |
era | 1993-2001 |
era_facet | 1993-2001 |
format | Book |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01511nam a2200361zcb4500</leader><controlfield tag="001">BV023590274</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20090806 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">021128s2003 xxu |||| 00||| eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)249017623</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV023590274</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">xxu</subfield><subfield code="c">XD-US</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-521</subfield><subfield code="a">DE-19</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">15,3</subfield><subfield code="2">ssgn</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Duggan, Mark G.</subfield><subfield code="d">1970-</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)129714402</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Does Medicaid pay too much for precscription drugs?</subfield><subfield code="b">a case study of atypical anti-psychotics</subfield><subfield code="c">Mark G. Duggan</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Cambridge, Mass.</subfield><subfield code="b">National Bureau of Economic Research</subfield><subfield code="c">2003</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">34, [15] S.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series</subfield><subfield code="v">9626</subfield></datafield><datafield tag="648" ind1=" " ind2="4"><subfield code="a">1993-2001</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medicaid</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Verschreibungspflichtiges Arzneimittel</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Gesetzliche Krankenversicherung / Sozialhilfeempfänger / Pharmazeutisches Produkt / Psychopharmakon / Preis / Gesundheitskosten / Innovation / Produktivität / Gesundheit / Schätzung / Kalifornien / USA</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Online-Ausgabe</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series</subfield><subfield code="v">9626</subfield><subfield code="w">(DE-604)BV002801238</subfield><subfield code="9">9626</subfield></datafield><datafield tag="856" ind1="4" ind2="1"><subfield code="u">http://papers.nber.org/papers/w9626.pdf</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-016905604</subfield></datafield></record></collection> |
id | DE-604.BV023590274 |
illustrated | Not Illustrated |
index_date | 2024-07-02T22:41:26Z |
indexdate | 2024-07-09T21:25:08Z |
institution | BVB |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-016905604 |
oclc_num | 249017623 |
open_access_boolean | 1 |
owner | DE-521 DE-19 DE-BY-UBM |
owner_facet | DE-521 DE-19 DE-BY-UBM |
physical | 34, [15] S. |
publishDate | 2003 |
publishDateSearch | 2003 |
publishDateSort | 2003 |
publisher | National Bureau of Economic Research |
record_format | marc |
series | National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series |
series2 | National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series |
spelling | Duggan, Mark G. 1970- Verfasser (DE-588)129714402 aut Does Medicaid pay too much for precscription drugs? a case study of atypical anti-psychotics Mark G. Duggan Cambridge, Mass. National Bureau of Economic Research 2003 34, [15] S. txt rdacontent n rdamedia nc rdacarrier National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series 9626 1993-2001 Medicaid Verschreibungspflichtiges Arzneimittel Gesetzliche Krankenversicherung / Sozialhilfeempfänger / Pharmazeutisches Produkt / Psychopharmakon / Preis / Gesundheitskosten / Innovation / Produktivität / Gesundheit / Schätzung / Kalifornien / USA Erscheint auch als Online-Ausgabe National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series 9626 (DE-604)BV002801238 9626 http://papers.nber.org/papers/w9626.pdf kostenfrei Volltext |
spellingShingle | Duggan, Mark G. 1970- Does Medicaid pay too much for precscription drugs? a case study of atypical anti-psychotics National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series Medicaid Verschreibungspflichtiges Arzneimittel Gesetzliche Krankenversicherung / Sozialhilfeempfänger / Pharmazeutisches Produkt / Psychopharmakon / Preis / Gesundheitskosten / Innovation / Produktivität / Gesundheit / Schätzung / Kalifornien / USA |
title | Does Medicaid pay too much for precscription drugs? a case study of atypical anti-psychotics |
title_auth | Does Medicaid pay too much for precscription drugs? a case study of atypical anti-psychotics |
title_exact_search | Does Medicaid pay too much for precscription drugs? a case study of atypical anti-psychotics |
title_exact_search_txtP | Does Medicaid pay too much for precscription drugs? a case study of atypical anti-psychotics |
title_full | Does Medicaid pay too much for precscription drugs? a case study of atypical anti-psychotics Mark G. Duggan |
title_fullStr | Does Medicaid pay too much for precscription drugs? a case study of atypical anti-psychotics Mark G. Duggan |
title_full_unstemmed | Does Medicaid pay too much for precscription drugs? a case study of atypical anti-psychotics Mark G. Duggan |
title_short | Does Medicaid pay too much for precscription drugs? |
title_sort | does medicaid pay too much for precscription drugs a case study of atypical anti psychotics |
title_sub | a case study of atypical anti-psychotics |
topic | Medicaid Verschreibungspflichtiges Arzneimittel Gesetzliche Krankenversicherung / Sozialhilfeempfänger / Pharmazeutisches Produkt / Psychopharmakon / Preis / Gesundheitskosten / Innovation / Produktivität / Gesundheit / Schätzung / Kalifornien / USA |
topic_facet | Medicaid Verschreibungspflichtiges Arzneimittel Gesetzliche Krankenversicherung / Sozialhilfeempfänger / Pharmazeutisches Produkt / Psychopharmakon / Preis / Gesundheitskosten / Innovation / Produktivität / Gesundheit / Schätzung / Kalifornien / USA |
url | http://papers.nber.org/papers/w9626.pdf |
volume_link | (DE-604)BV002801238 |
work_keys_str_mv | AT dugganmarkg doesmedicaidpaytoomuchforprecscriptiondrugsacasestudyofatypicalantipsychotics |